ASCLETIS-B (01672.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec3

Gallant Biopharm repurchased 1.306 million shares for HKD 15.9275 million

09:24

Nov11

Galore Pharmaceuticals-B Selects ASC36 as Clinical Development Candidate

07:23

Nov5

GALY Pharma-B repurchases 100,000 shares at a cost of HKD 9.24 million

11:02

Galore Pharmaceuticals Announces Positive Phase I Clinical Trial Results for ASC30 Obesity Treatment Candidate

00:03

Oct31

Galore Pharmaceutical-B repurchased shares

10:57

Oct30

Galore Pharmaceutical-B Selects ASC36 as Clinical Development Candidate

00:09

Schedules & Filings

Schedules

Filings

Aug15

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 591.59 K, Net Income -48.13 M, EPS -0.05

Gere Pharmaceutical (1672.HK) 2025 Mid-Year Performance Conference Call

Mar26

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 682.46 K, Net Income -90.76 M, EPS -0.0919

Aug30

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Net Income -70.02 M, EPS -0.0688

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change